NCT00296647 - Smoking Cessation Intervention: Effectiveness in Primary Care | Biotech Hunter

Enrollment

1,346

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

December 31, 2010

Conditions

Tobacco Dependence

Interventions

DRUG

nicotine patch

Decreasing dosages from 21 to 7 mg over 12 week period

DRUG

nicotine patch

Decreasing dosage from 21 to 7 mg over 12 weeks

DRUG

nicotine lozenge

4 mg nicotine lozenge: dosage according to package directions for 16 weeks

DRUG

bupropion

dosage according to prescription directions: 12 weeks

DRUG

patch + lozenge

dosage of each according to package insert directions (12 weeks patch, 16 weeks lozenge)

DRUG

bupropion + lozenge

dosage of each according to prescription or package insert (12 weeks bupropion, 16 weeks lozenge)

Trial Locations (1)

UW-CTRI Milwaukee Research site, Milwaukee

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Wisconsin, Madison

OTHER